A carregar...
Immune Phenotype and Immune Checkpoint Inhibitors for the Treatment of Human Hepatocellular Carcinoma
Immunotherapies are promising approaches for treating hepatocellular carcinomas (HCCs) refractory to conventional therapies. However, a recent clinical trial of immune checkpoint inhibitors (ICIs) revealed that anti-tumor responses to ICIs are not satisfactory in HCC cases. Therefore, it is critical...
Na minha lista:
| Publicado no: | Cancers (Basel) |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7281618/ https://ncbi.nlm.nih.gov/pubmed/32443599 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12051274 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|